Pharmafile Logo

Cuttsy+Cuttsy launches R:SQD – a new way to predict and improve trial success

Cuttsy+Cuttsy has launched R:SQD, an innovative recruitment and retention success scoring tool that helps clinical trial sponsors predict, measure, and improve participant engagement and trial outcomes.

R:SQD logo

R:SQD, a groundbreaking recruitment and retention success scoring tool that gives clinical trial sponsors the evidence, insight, and confidence to design and deliver truly participant-centred studies, has launched today.

By blending trial data with patient insights, R:SQD delivers a clear, evidence-based score showing how ready a trial is to attract, recruit, and retain participants, as well as providing tailored recommendations to strengthen engagement and protect trial outcomes.

A new kind of trial health check

R:SQD provides a rapid, evidence-based assessment of how participant-ready a study really is. Its unique scoring system reveals the barriers that may be limiting recruitment or driving dropouts, while expert-driven recommendations help sponsors act early, remove friction, and build trust with participants.

“When recruitment slows or retention drops, it can be hard to see what’s really holding a trial back,” said Stacey Davidson, Head of Strategy and Content at Cuttsy+Cuttsy. “R:SQD cuts through the noise, combining data and empathy to deliver clarity, confidence, and practical next steps. It’s about turning insight into action – helping today’s trials become tomorrow’s breakthroughs.”

Supporting every stage of the trial journey

R:SQD is designed to add value across the full trial lifecycle, whether teams are rescuing an underperforming study, planning a launch, or designing a protocol.

  • Study rescue: When a trial is struggling, R:SQD delivers a rapid health check and recovery plan, pinpointing participant-experience fail points and guiding sponsors to regain momentum, protect timelines, and rebuild engagement.
  • Campaign planning: Ahead of launch, R:SQD predicts how ready a study is to support participants from day 1. Its readiness score and activation blueprint help leaders allocate resources effectively, identify risks early, and ensure every new trial starts strong.
  • Protocol consulting: By reviewing draft protocols through a participant lens, R:SQD highlights where complexity or burden could affect enrolment and retention,  helping teams design trials that are not only scientifically robust but also patient-ready and practical in the real world.

Turning data into difference

Unlike traditional analytics platforms, R:SQD blends quantitative insight with human understanding. Its tailored recommendations provide clear, evidence-based actions that make trials more inclusive, efficient, and participant friendly.

“R:SQD reflects our belief that people should be at the heart of every clinical trial,” said Mathew Cutts, Co-Founder and Director of Cuttsy+Cuttsy. “By giving sponsors the tools to see, understand, and address the real barriers to participation, we can help create studies that deliver better experiences and better results.”

Ready to give your trial a health check?

R:SQD is now available to pharmaceutical companies, CROs, and research organisations seeking to strengthen recruitment, retention, and participant engagement strategies.

Discover how R:SQD can put your trial on track for success. Talk to our team.

This content was provided by Cuttsy + Cuttsy

Company Details

 Latest Content from  Cuttsy + Cuttsy 

Clinical research in 2026: The trends shaping tomorrow

Discover the key trends shaping clinical research in 2026, from patient-centric approaches to empowering site staff and fostering stronger human connections.

From overwhelming to actionable: Bringing lifestyle guidance to life

Discover how clear communication and health literacy principles can transform complex patient materials into simple, engaging, and empowering health information.

Behind the scenes: why we created ‘The participation equation’

Go behind the scenes of The participation equation – our call to put people, not just data, at the heart of clinical research.

Cuttsy+Cuttsy launches R:SQD – a new way to predict and improve trial success

Cuttsy+Cuttsy has launched R:SQD, an innovative recruitment and retention success scoring tool that helps clinical trial sponsors predict, measure, and improve participant engagement and trial outcomes.

New report, The participation equation, uncovers key drivers of patient engagement in clinical trials

Cuttsy+Cuttsy’s new report, The participation equation, uncovers what drives patient engagement and retention in modern clinical trials through insights from over 700 participants and industry experts.

Why patients drop out of weight management trials and what you can do about it

Discover the key barriers to retention in obesity and weight-management trials and explore actionable, patient-centered strategies to improve engagement, outcomes, and data reliability.

Cuttsy+Cuttsy welcomes new team members

Cuttsy+Cuttsy is excited to announce the addition of three talented professionals to the team: Flo, an enthusiastic Account Executive; Vicki, a creative Graphic Designer; and Jo, a detail-driven Artworker

Designing with patients in mind: How to build more inclusive clinical trials

Discover how patient-centred design transforms inclusive clinical trials. Learn to overcome trial recruitment challenges by listening to patients and creating studies that fit real lives.

Why fresh patient voices are critical to improve clinical trials outcomes

Discover why diverse patient voices, especially first-time participants, are key to improving clinical trials. Boost recruitment, retention, and patient-centric research.

Using patient personas to add a personal touch to clinical trial recruitment and retention

Discover how patient personas can revolutionise clinical trial recruitment and retention. Personalise outreach, build trust, and improve patient engagement.